Wednesday, April 22, 2026
35 C
Bengaluru

Partner Don’t Punish

[wpfilebase tag=file id=74 tpl=download-button /]

Inside this Issue

1. Three Simple Ways to Step Up Your Role as a Firstline Leaders by Vivek Hattangadi

Using Empathy, Focus and Presentation to earn the confidence of your team and produce outstanding results.

2. What Makes a Brand Management Strategy Successful? by Genesh Kuriakose

What every Pharma Brand Manager needs to know about crafting a successful Brand Strategy over the lifecycle of a product.

3. Application of Porter’s 5 to Pharma Marketing by Pankaj Mehrotra

A tried-and-tested competition analysis framework, applied seamlessly to pharma.

4. Market and Morals in Pharma by Salil Kallianpur

Free markets are by nature amoral. To get moral (or ’just’) outcomes from an amoral market requires a well-developed governance system – which India presently lacks.

5. NOT Business as Usual by Jay Mehta

How the New Generation of Pharma Professionals Will Embrace Change and Disruption.

Hot this week

Precision Farming Market to Witness Promising Growth Opportunities by 2024-2035

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Precision Farming Market to Witness Promising Growth Opportunities by 2024-2035

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img